Organogenesis readies new expansion plans

With the first phase of its expansion plan complete, Canton, MA-based Organogenesis is now blueprinting a new R&D center and manufacturing plant. The biotech says that it will have invested $63 million in the expansion by the time it is all completed in 2013. The developer also says that Saudi officials have approved its treatment for chronic wounds and foot ulcers. Story